226 related articles for article (PubMed ID: 36895039)
21. 10-Gingerol Targets Lipid Rafts Associated PI3K/Akt Signaling in Radio-Resistant Triple Negative Breast Cancer Cells.
Ediriweera MK; Moon JY; Nguyen YT; Cho SK
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664351
[TBL] [Abstract][Full Text] [Related]
22. HOXD8 inhibits the proliferation and migration of triple-negative breast cancer cells and induces apoptosis in them through regulation of AKT/mTOR pathway.
Zhang Y; Yu Y; Su X; Lu Y
Reprod Biol; 2021 Dec; 21(4):100544. PubMed ID: 34454307
[TBL] [Abstract][Full Text] [Related]
23. Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways.
Qu Z; Lin Y; Mok DK; Bian Q; Tai WC; Chen S
Int J Med Sci; 2020; 17(11):1482-1490. PubMed ID: 32669950
[TBL] [Abstract][Full Text] [Related]
24. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
Cheng W; Liu D; Guo M; Li H; Wang Q
Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
[TBL] [Abstract][Full Text] [Related]
25. Mere15, a novel polypeptide from Meretrix meretrix, inhibits proliferation and metastasis of human non-small cell lung cancer cells through regulating the PI3K/Akt/mTOR signaling pathway.
Xu B; Guo M; Ma L; Farooqi AA; Wang L; Qiao G; Liu M; Zuo L; Ye H; Lin X; Cao S
Neoplasma; 2021 Nov; 68(6):1181-1189. PubMed ID: 34585588
[TBL] [Abstract][Full Text] [Related]
26. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
Zhang H; Zheng J; Fu Y; Ling J; Liu Z; Lin X; Dong X; Sun Y; Tan T; Guo Z; Xie G
Breast Cancer Res Treat; 2023 Apr; 198(3):437-446. PubMed ID: 36797433
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways.
Martínez-Revollar G; Garay E; Martin-Tapia D; Nava P; Huerta M; Lopez-Bayghen E; Meraz-Cruz N; Segovia J; González-Mariscal L
Exp Cell Res; 2015 Nov; 339(1):67-80. PubMed ID: 26453937
[TBL] [Abstract][Full Text] [Related]
29. Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway
Meng M; Yang Q; Ouyang Z; Yang Q; Wu X; Huang Y; Su Y; Chen S; Chen W
Acta Pharm; 2023 Mar; 73(1):75-90. PubMed ID: 36692465
[TBL] [Abstract][Full Text] [Related]
30. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway.
Zhang LY; Zhang YQ; Zeng YZ; Zhu JL; Chen H; Wei XL; Liu LJ
Breast Cancer Res Treat; 2020 Jul; 182(1):21-33. PubMed ID: 32415497
[TBL] [Abstract][Full Text] [Related]
31. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
32. Natural Prenylated Xanthones as Potential Inhibitors of PI3k/Akt/mTOR Pathway in Triple Negative Breast Cancer Cells.
Nguyen TTH; Qu Z; Nguyen VT; Nguyen TT; Le TTA; Chen S; Ninh ST
Planta Med; 2022 Oct; 88(13):1141-1151. PubMed ID: 34963183
[TBL] [Abstract][Full Text] [Related]
33. Rosmarinic acid inhibits proliferation and invasion of hepatocellular carcinoma cells SMMC 7721 via PI3K/AKT/mTOR signal pathway.
Wang L; Yang H; Wang C; Shi X; Li K
Biomed Pharmacother; 2019 Dec; 120():109443. PubMed ID: 31541884
[TBL] [Abstract][Full Text] [Related]
34. KK-LC-1 as a therapeutic target to eliminate ALDH
Bu J; Zhang Y; Wu S; Li H; Sun L; Liu Y; Zhu X; Qiao X; Ma Q; Liu C; Niu N; Xue J; Chen G; Yang Y; Liu C
Nat Commun; 2023 May; 14(1):2602. PubMed ID: 37147285
[TBL] [Abstract][Full Text] [Related]
35. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
[TBL] [Abstract][Full Text] [Related]
36. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
Humphries BA; Cutter AC; Buschhaus JM; Chen YC; Qyli T; Palagama DSW; Eckley S; Robison TH; Bevoor A; Chiang B; Haley HR; Sahoo S; Spinosa PC; Neale DB; Boppisetti J; Sahoo D; Ghosh P; Lahann J; Ross BD; Yoon E; Luker KE; Luker GD
Breast Cancer Res; 2020 Jun; 22(1):60. PubMed ID: 32503622
[TBL] [Abstract][Full Text] [Related]
37. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.
Sun Y; Xu Y; Xu J; Lu D; Wang J
Int J Clin Exp Pathol; 2015; 8(8):9081-8. PubMed ID: 26464650
[TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
40. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]